The Role of Rituximab in Chronic Lymphocytic Leukemia Treatment and the Potential Utility of Biosimilars

Chronic lymphocytic leukemia (CLL) is managed with observation for asymptomatic or clinically silent disease; pharmacologic intervention is generally required for symptomatic patients with clinically significant adenopathy or cytopenia. In the front‐line treatment of CLL, the current standard‐of‐car...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Brown, Jennifer R., Cymbalista, Florence, Sharman, Jeff, Jacobs, Ira, Nava‐Parada, Pilar, Mato, Anthony
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2017
Témata:
Academia‐Pharma Intersect: Hematologic Malignancies
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5905689/
https://ncbi.nlm.nih.gov/pubmed/29212732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0150
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky